Overview of Dr. Latif
Dr. Farhana Latif is a cardiologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and NYU Langone Hospitals. She received her medical degree from Albany Medical College and has been in practice 19 years. She is one of 533 doctors at NYU Langone Hospitals and one of 706 doctors at New York-Presbyterian Hospital who specialize in Cardiology. She has more than 70 publications and over 500 citings.
Office
622 W 168th St
Ph-3 Stem 137
New York, NY 10032Fax+1 212-342-3414
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 2002 - 2007
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1998 - 2001
- Albany Medical CollegeClass of 1998
Certifications & Licensure
- FL State Medical License 2022 - Present
- NY State Medical License 2001 - 2027
- NJ State Medical License 2008 - 2009
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- PET/CT with Myocardial Blood Flow Assessment Is Prognostic of Cardiac Allograft Vasculopathy Progression and Clinical Outcomes.Nikil Prasad, Erin Harris, Ersilia M DeFilippis, Gabriel Sayer, Margarita Chernovolenko
Journal of Nuclear Medicine. 2025-02-03 - Outcomes After Heart Transplantation Among Non-Native English-Speaking Recipients.Fabian Vargas, Jaya Batra, Carolina Lemos, Ella Magun, Ruben A Salazar
Journal of Cardiac Failure. 2025-01-20 - 1 citationsBridge to simultaneous heart-kidney transplantation via extracorporeal life support: National outcomes in the new heart allocation policy era.Iris Feng, Paul A Kurlansky, Yanling Zhao, Krushang Patel, Morgan K Moroi
The Journal of Heart and Lung Transplantation. 2025-01-01
Journal Articles
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019Farhana Latif, Maryjane A Farr, Kevin J Clerkin, Koji Takeda, Yoshifumi Naka, Susan Restaino, Gabriel Sayer, Nir Uriel, JAMA Cardiology
Authored Content
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
- Characteristics and Outcomes of Recipients of Heart Transplant with Coronavirus Disease 2019May 2020
- Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
- Outcomes Associated with Mammalian Target of Rapamycin (mTOR) Inhibitors in Heart Transplant Recipients: A Meta-Analysis☆March 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: